Profilo
Iris Alroy is the founder of ProMining Therapeutics Ltd.
(founded in 2011) and Anima Biotech, Inc. (founded in 2014).
At Anima Biotech, Inc., Dr. Alroy holds the title of Chief Scientific Officer since 2014.
Dr. Alroy also held the position of Vice President-Research at W World Corp.
Posizioni attive di Iris Alroy
| Società | Posizione | Inizio |
|---|---|---|
Anima Biotech, Inc.
 Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Fondatore | 01/01/2014 |
Precedenti posizioni note di Iris Alroy
| Società | Posizione | Fine |
|---|---|---|
ProMining Therapeutics Ltd.
 ProMining Therapeutics Ltd. BiotechnologyHealth Technology ProMining Therapeutics Ltd. provides biopharmaceutical research and development services. It is an early-stage biopharmaceutical research and development company engaged in the discovery and development of novel oral, small-molecule drugs for treatment of cancer, inflammation, chronic pain, and cardiovascular and viral diseases. The company was founded in 2011 and is headquartered in Nes Ziona, Israel. | Fondatore | - |
| W WORL | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| W WORL | Health Technology |
| Aziende private | 2 |
|---|---|
ProMining Therapeutics Ltd.
ProMining Therapeutics Ltd. BiotechnologyHealth Technology ProMining Therapeutics Ltd. provides biopharmaceutical research and development services. It is an early-stage biopharmaceutical research and development company engaged in the discovery and development of novel oral, small-molecule drugs for treatment of cancer, inflammation, chronic pain, and cardiovascular and viral diseases. The company was founded in 2011 and is headquartered in Nes Ziona, Israel. | Health Technology |
Anima Biotech, Inc.
Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Health Technology |
- Borsa valori
- Insiders
- Iris Alroy
